Publications

A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

 49
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

Tags:

Previous Article

Monitoring dynamic single-cell events using noninvasive methods

Next Article

A next-generation HDAC6 inhibitor for ALS treatment

Related Posts

RANK drives structured intestinal epithelial expansion during pregnancy

RANK drives structured intestinal epithelial expansion ...

 105

Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan- associated neurodegenerative disease

Glycogen synthase GYS1 overactivation contributes to g...

 91

Harnessing microglia-based cell therapies for the treatment of neurodegenerative diseases

Harnessing microglia-based cell therapies for the treat...

 108